AffaMed Therapeutics 宣布与EverInsight Therapeutics达成最终合并协议并任命赵大尧博士为CEO
October 14, 2020 05:51 ET
|
AffaMed Therapeutics
中国上海, Oct. 14, 2020 (GLOBE NEWSWIRE) -- 致力于开发和商业化具有革新价值的药物以满足大中华地区和全球患者在中枢神经系统和眼科方面未满足的关键医疗需求的生物医药公司AffaMed Therapeutics (“AffaMed”) 今天宣布与生物医药公司EverInsight Therapeutics（“EverInsight”）达成最终合并协议。 ...
AffaMed Therapeutics Announces Merger with EverInsight Therapeutics and Appoints Dayao Zhao, M.D., Ph.D. as CEO
October 14, 2020 04:42 ET
|
AffaMed Therapeutics
SHANGHAI, China, Oct. 14, 2020 (GLOBE NEWSWIRE) -- AffaMed Therapeutics (“AffaMed”), a biopharmaceutical company focused on developing and commercializing transformative therapeutics to address...